ArticleHemaSphere2022

First-line Treatment With Bendamustine and Rituximab for Old and Frail Patients With Aggressive Lymphoma: Results of the B-R-ENDA Trial.

Friederike Braulke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.